These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6327851)

  • 1. Complement-dependent, Epstein-Barr virus-neutralizing antibody appearing early in the sera of patients with infectious mononucleosis.
    Sairenji T; Sullivan JL; Humphreys RE
    J Infect Dis; 1984 May; 149(5):763-8. PubMed ID: 6327851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Epstein-Barr virus production in P3HR-1 cells by Epstein-Barr virus-seropositive human serum.
    Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Humphreys RE
    Intervirology; 1991; 32(1):37-51. PubMed ID: 1849877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV.
    Bu W; Hayes GM; Liu H; Gemmell L; Schmeling DO; Radecki P; Aguilar F; Burbelo PD; Woo J; Balfour HH; Cohen JI
    Clin Vaccine Immunol; 2016 Apr; 23(4):363-9. PubMed ID: 26888186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection.
    Tanner JE; Diaz-Mitoma F; Rooney CM; Alfieri C
    J Infect Dis; 1997 Dec; 176(6):1454-61. PubMed ID: 9395354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides.
    Sculley DG; Sculley TB; Pope JH
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2253-8. PubMed ID: 3020161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders.
    Tanner JE; Wei MX; Alfieri C; Ahmad A; Taylor P; Ooka T; Menezes J
    J Infect Dis; 1997 Jan; 175(1):38-46. PubMed ID: 8985194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
    Miller G; Coope D; Niederman J; Pagano J
    J Virol; 1976 Jun; 18(3):1071-80. PubMed ID: 178913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.
    Ooka T; de Turenne-Tessier M; Stolzenberg MC
    Springer Semin Immunopathol; 1991; 13(2):233-47. PubMed ID: 1664988
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response to Epstein-Barr virus in infectious mononucleosis.
    Nikoskelainen J; Hänninen P
    Infect Immun; 1975 Jan; 11(1):42-51. PubMed ID: 163790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance and diagnosis of Epstein-Barr virus infection].
    Kuljić-Kapulica N; Krstić L; Budisin A; Kapulica I; Bojić I; Malesević M; Kalinić-Andrić V
    Vojnosanit Pregl; 1991; 48(4):313-6. PubMed ID: 1660212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay for detection of antibodies to Epstein-Barr virus in human infectious mononucleosis serum specimens.
    Hutchinson HD; Ziegler DW; Feorino PM
    J Clin Microbiol; 1975 May; 1(5):429-33. PubMed ID: 170314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis].
    Imai S
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):481-92. PubMed ID: 2172132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infections.
    Middleton PJ
    Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproliferative syndrome as a model.
    Purtilo DT
    Adv Cancer Res; 1981; 34():279-312. PubMed ID: 6269372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.